![](/img/cover-not-exists.png)
Response of ovarian carcinomas to gefitinib–carboplatin–paclitaxel combination is not associated with EGFR kinase domain somatic mutations
Ludovic Lacroix, Patricia Pautier, Pierre Duvillard, Nelly Motté, Patrick Saulnier, Jean-Michel Bidart, Jean-Charles SoriaVolume:
118
Year:
2006
Language:
english
Pages:
2
DOI:
10.1002/ijc.21460
File:
PDF, 51 KB
english, 2006